연구성과로 돌아가기
2023 연구자 정보 (49 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kwon, Young Nam (Kwon, YN) |
Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul, South Korea Seoul Metropolitan Govt, Dept Neurol, Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea Seoul Natl Univ, Dept Med, Coll Med, Seoul, South Korea |
|
0000-0002-3588-274X Kwon, Young Nam |
[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum [JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum [JCR상위 13.4] Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis |
SCIE | 1.5 |
CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY CLINICAL NEUROLOGY;NEUROSCIENCES CLINICAL NEUROLOGY |
bjkim@skku.edu;sueh916@gmail.com; paddy.waters@ndcn.ox.ac.uk;nrhong@gmail.com; |
||
|
Lee, E. (Lee, E) |
제1저자 |
Kyungpook Natl Univ, Chilgok Hosp, Thorac Surg, Daegu, South Korea Kyungpook Natl Univ, Daegu, South Korea |
|
|
[JCR상위 1.5] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study [JCR상위 39.4] Nitric Oxide-releasing Zinc Oxide And Melatonin-modulated Extracellular Vesicles In Multiplexed PLGA Scaffolds For Chronic Kidney Disease |
SCIE | 1.5 |
ONCOLOGY;RESPIRATORY SYSTEM CELL & TISSUE ENGINEERING;CELL BIOLOGY;ENGINEERING, BIOMEDICAL;MATERIALS SCIENCE, BIOMATERIALS |
||
|
Lee, Gyeong Won (Lee, GW) |
Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Coll Med, Dept Internal Med, Jinju, South Korea |
|
|
[JCR상위 1.5] A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Study | SCIE | 1.5 | HEMATOLOGY | |||
|
Lee, Ho Sup (Lee, HS) |
Kosin Univ, Gospel Hosp, Busan, South Korea Kosin Univ, Gospel Hosp, Dept Internal Med, Div Hematol Oncol,Coll Med, Busan, South Korea Kosin Univ, Dept Internal Med, Coll Med, Busan, South Korea Kosin Univ, Gospel Hosp, Dept Internal Med, Div Hematol,Coll Med, Pusan, South Korea Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea Kosin Univ, Coll Med, Busan, South Korea |
|
|
[JCR상위 1.5] Multicenter, Prospective Study to Investigate the Efficacy and Safety of IntravenousImmunoglobulin Therapy in Elderly Patients with Diffuse Large B Cell Lymphoma Treated with R-Mini-CHOP [JCR상위 28.1] Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study [JCR상위 35.6] Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: a nationwide cohort study by the Korean multiple myeloma working party (KMM 2202) [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) |
SCIE | 1.5 |
HEMATOLOGY MEDICINE, GENERAL & INTERNAL HEMATOLOGY;ONCOLOGY |
jhmoon@knu.ac.kr; sksohn@knu.ac.kr; |
||
|
Lee, Hye Lim (Lee, HL) |
Korea Univ, Dept Neurol, Coll Med, Seoul, South Korea Korea Univ, Coll Med, Dept Neurol, Seoul, South Korea |
|
|
[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum [JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum |
SCIE | 1.5 |
CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY CLINICAL NEUROLOGY;NEUROSCIENCES |
bjkim@skku.edu;sueh916@gmail.com; | ||
|
Lee, Hyewon (Lee, H) |
Natl Canc Ctr, Goyang, South Korea |
A-8012-2012 LEE, SEOK-YONG |
|
[JCR상위 1.5] The Co-Occurrence of bZIP in-Frame CEBPA-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia | SCIE | 1.5 | HEMATOLOGY | |||
|
Lee, J. C. (Lee, JC) |
Univ Ulsan, Coll Med, Asan Med Cenc, Seoul, South Korea |
|
|
[JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy | SCIE | 1.5 | ONCOLOGY;RESPIRATORY SYSTEM | |||
|
Lee, Jae Cheol (Lee, JC) |
Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 05505, South Korea |
AAA-2678-2021 Lee, Jae |
|
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR [JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial [JCR상위 28.4] Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer |
SCIE | 1.5 |
ONCOLOGY;RESPIRATORY SYSTEM CELL BIOLOGY ONCOLOGY |
droij@jnu.ac.kr; ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; jclee@amc.seoul.kr; |
||
|
Lee, Jeong Yeop (Lee, JY) |
Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea Chonnam Natl Univ, Med Sch, Dept Radiol, Hwasun, Jeonnam, South Korea |
|
|
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR | SCIE | 1.5 | ONCOLOGY;RESPIRATORY SYSTEM | droij@jnu.ac.kr; | ||
|
Lee, Ji Hyun (Lee, JH) |
Dong A Univ, Coll Med, Busan, South Korea Daegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea Dong A Univ Hosp, Dept Hematol Oncol, Busan, South Korea Dong A Univ, Dept Internal Med, Coll Med, Busan, South Korea Seoul Song Do Colorectal Hosp, Digest Endoscop Ctr, Seoul, South Korea Dong A Univ, Dept Internal Med, Div Hematol Oncol, Coll Med, Busan, South Korea Dong A Univ, Coll Med, Seoul, South Korea Korea Univ, Korea Univ Ansan Hosp, Dept Dermatol, Coll Med, Ansan, South Korea Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea |
ABC-6119-2021 JZC-9591-2024 LEE, HYUN Lee, JiHyun |
0000-0003-2341-4911 Lee, Ji Hyun |
[JCR상위 1.5] Multicenter, Prospective Study to Investigate the Efficacy and Safety of IntravenousImmunoglobulin Therapy in Elderly Patients with Diffuse Large B Cell Lymphoma Treated with R-Mini-CHOP [JCR상위 9.4] The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study [JCR상위 28.1] Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma (vol 38, pg 238, 2023) [JCR상위 28.1] Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/ refractory multiple myeloma [JCR상위 69.6] Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma [JCR상위 35.6] Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study [JCR상위 35.6] Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia [JCR상위 43.0] Comparison of the Pharmacokinetics of CT-P13 Between Crohn's Disease and Ulcerative Colitis [JCR상위 4.6] Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation [JCR상위 35.6] Carfilzomib, lenalidomide, and dexamethasone combination chemotherapy in the real-world 364 Asian multiple myeloma patients on behalf of the Korean multiple myeloma working party (KMM2201 study) [JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) [JCR상위 62.2] Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea (vol 34, pg 419, 2022) |
SCIE | 1.5 |
HEMATOLOGY ENDOCRINOLOGY & METABOLISM MEDICINE, GENERAL & INTERNAL HEMATOLOGY;ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY DERMATOLOGY |
kcwon@med.yu.ac.kr; jhmoon@knu.ac.kr; jhmoon@knu.ac.kr;kihyunkimk@gmail.com; dandy813@hanmail.net;knuhkim@gmail.com;diksmc.park@samsung.com;hjkim@khmc.or.kr;doctorlyj@naver.com;jskoo@korea.ac.kr;silverkes@naver.com;bodnsoul@hanmail.net;chelsia3@naver.com;giwkim@hanmail.net;shsj9128@ajou.ac.kr;mdkhwook@gmail.com;hyskim@yonsei.ac.kr;pys1109@eulji.ac.kr;yousunk69@korea.com;kto0440@paik.ac.kr;leejun@chosun.ac.kr;gicch@cau.ac.kr;hands@hanyang.ac.kr;j40479@gmail.com;dshskim@chonnam.ac.kr; sksohn@knu.ac.kr; |
||
|
Lee, Kyoo Hyung (Lee, KH) |
Asan Med Ctr, Seoul, South Korea |
|
|
[JCR상위 1.5] Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) | SCIE | 1.5 | HEMATOLOGY | |||
|
Lee, Myung-won (Lee, MW) |
Chungnam Natl Univ Hosp, Daejeon, South Korea |
|
|
[JCR상위 1.5] Cardiovascular Toxicity after Carfilzomib, Lenalidomide, and Dexamethasone Combination Chemotherapy in the Real-World 364 Asian Multiple Myeloma Patients on Behalf of the Korean Multiple Myeloma Working Party (KMM2201 study) | SCIE | 1.5 | HEMATOLOGY | |||
|
Lee, S. Y. (Lee, SY) |
Kyungpook Natl Univ, Chilgok Hosp, Dept Internal Med, Daegu, South Korea Korea Univ, Coll Med, Guro Hosp, Seoul, South Korea Kyungpook Natl Univ, Sch Med, Daegu, South Korea Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea |
|
|
[JCR상위 1.5] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study [JCR상위 1.5] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy [JCR상위 1.1] Enhancing lung nodule discrimination with a novel cfDNA test: The cancer signature ensemble (CSE) approach |
SCIE | 1.1 |
ONCOLOGY;RESPIRATORY SYSTEM ONCOLOGY |
|||
|
Min, Ju-Hong (Min, JH) |
Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea |
|
|
[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum [JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum |
SCIE | 1.5 |
CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY CLINICAL NEUROLOGY;NEUROSCIENCES |
bjkim@skku.edu;sueh916@gmail.com; | ||
|
Min, Young Gi (Min, YG) |
Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea |
|
|
[JCR상위 1.5] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum [JCR상위 13.4] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum |
SCIE | 1.5 |
CLINICAL NEUROLOGY;PSYCHIATRY;SURGERY CLINICAL NEUROLOGY;NEUROSCIENCES |
bjkim@skku.edu;sueh916@gmail.com; |
페이지 이동: